Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour-Reference-Cited by-同舟云学术

Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour

Published:2007-05 Issue:5 Volume:99 Page:993-997
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Shayegan Bobby,Carver Brett S.,Stasi Jason,Motzer Robert J.,Bosl George J.,Sheinfeld Joel

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.06740.x/fullpdf

Reference14 articles.

1. Testicular Germ-Cell Cancer

2. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.

3. Impact of symptomatic interval on prognosis of patients with stage III testicular cancer

4. The international germ cell consensus classification: A new prognostic factor-based staging classification for metastatic germ cell tumours

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growing teratoma syndrome in children and adolescents: Prevalence and surgical outcome;Pediatric Blood & Cancer;2024-06-04

2. Expertise Area 3.2: Testicular cancer;Rare and Complex Urology;2024

3. Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors;Journal of Clinical Oncology;2023-08-10

4. Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults;Journal of Clinical Oncology;2023-08-10

5. Testis Cancer;Holland‐Frei Cancer Medicine;2022-10-21